Additionally, JC Ma et al. [36] proposed a new prognostic nomogram based on 1118 BC patients after NAC, revealing that locoregional recurrence control is improved after radiotherapy in the HR+, HER2− BC subtype, which was supported by our study’s findings. The gene discussed is ERBB2; the disease is breast cancer.